Get caught up with Contemporary OB/GYN's latest coverage from The Menopause Society Annual Meeting in San Diego, California.
|Podcasts|March 18, 2020
Making Sense of TB Testing Guidelines
Sponsored Content
Advertisement
Listen to our Podcast on
Listen to our Podcast on
Download our Supplement on
Stephanie Ros, MD, MSCI, discusses her criteria for testing, including social, institutional and vaccination history; as well as place of origin and prior diagnosis. Dr. Ros also reviews advantages of the interferon gamma release assay as a screening method and suggests next steps for patients testing positive.
Presented by: Stephanie Ros, MD, MSCI
Stephanie Ros, MD, MSCI is a high-risk pregnancy specialist with focuses on teaching, labor and birth, genetics, and helping patients who have experienced pregnancy loss. As an assistant residency program director, Dr. Ros supervises fellows, residents, and medical students.
Advertisement
Related to this article
Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Hormone therapy was associated with more frequent, longer migraines in postmenopausal women, but not with greater severity or analgesic use.
JoAnn V. Pinkerton, MD, offers primary care counseling on elinzanetant's side effects and the early onset and continued relief of hot flashes.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Stephanie S. Faubion, MD, on choosing between fezolinetant and elinzanetant, liver monitoring, follow-up, and open questions in menopause care.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
TMS 2026: HSDD biopsychosocial approach, night sweats red flags, misread WHI data
2
Neurokinin receptor antagonists improve menopausal sleep disturbance
3
How misread WHI data reshaped menopause care and training
4
Red flags that point beyond menopause in patients with night sweats
5